Reported Nov 16, 2022 · Terminated
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous…
Viatris Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Viatris Inc · 1000 Mylan Blvd · Canonsburg, PA · 15317-5853
Is this the product you have?
- Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only
- Manufactured forMylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy
- NDC
67457-246-00 (syringe)67457-246-01 (carton)
- Lot codes and dates
Lot #: AJ21002Exp. 03/2024
- Amount recalled
- 22400 syringes
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Viatris Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.